Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00163709
Status:
UNKNOWN
Last Update Posted:
2006-10-04
First Post:
2005-09-11
Brief Title:
BNP Testing in Patients With SOB on Presentation to ED
Sponsor:
Bayside Health
Organization:
Bayside Health
Study Overview
Official Title:
A Randomised Trial of BNP Testing in Patients With Shortness of Breath in the Emergency Department to Improve Patient Outcome
Status:
UNKNOWN
Status Verified Date:
2005-05
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A trial to examine whether a new heart failure blood test can improve the outcome of patients presenting to the Emergency Department with shortness of breath
We hypothesise that a BNP test performed in real-time in patients presenting to the Emergency Department with shortness of breath will help identify additional patients with CHF and consequently to change practice and allow more patients to recieve correct treatment earlier
We hypothesise that a BNP test performed in real-time in patients presenting to the Emergency Department with shortness of breath will help identify additional patients with CHF and consequently to change practice and allow more patients to recieve correct treatment earlier
Detailed Description:
In recent years new tests to diagnose heart failure have become available We are evaluating a new test called B-type natriuretic peptideBNPin patients presenting to the Emergency Department with shortness of breath Patients are randomised into whether they will receive the new test or not In the patient group where the test is positive standardised approach that will optimise heart failure treatment will be introduced We hypothesise that with this approach we will improve the clinical care of patients who present to the Emergency Department with shortness of breath Measures of outcomes will be the accuracy of diagnosis 2 hours after presentation 30 day mortality hospital and ICU admission rates and quality of life at 30days
We plan to investigate 600 consecutive patient presenting to the to the Emergency Department with shortness of breath that are over 40 years old and present with an emergency department triage category of 3 or higher Patients presenting with a traumatic cause of dyspnea patients with severe renal disease patients with cardiogenic shock and patients who have early transfer to another hospitalwithin 24 hrs will be excluded
We plan to investigate 600 consecutive patient presenting to the to the Emergency Department with shortness of breath that are over 40 years old and present with an emergency department triage category of 3 or higher Patients presenting with a traumatic cause of dyspnea patients with severe renal disease patients with cardiogenic shock and patients who have early transfer to another hospitalwithin 24 hrs will be excluded
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Heart Foundation Grant | None | None | None |